Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Extensive Stage Small Cell Lung Cancer × AMG 757 × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Small Cell Lung Carcinoma 8 Lung Neoplasms 3 Bites and Stings 2 Neuroendocrine Tumors 1 Neuroendocrine Prostate Cancer 1 Neoplasms 1 Extensive Stage Small Cell Lung Cancer 1

Interventions

Etoposide 9 Cisplatin 7 Carboplatin 5 camrelizumab 2 atezolizumab 2 Topotecan 2 Irinotecan 2 Drug Therapy 2 Bevacizumab 2 tislelizumab 1 temsirolimus 1 spartalizumab 1 oblimersen 1 obinutuzumab 1 lutetium Lu 177 dotatate 1 gossypol acetic acid 1 durvalumab 1 ceralasertib 1 apatinib 1 Temozolomide 1 Sirolimus 1 Podophyllotoxin 1 Platinum 1 Paclitaxel 1 NVP-BKM120 1 Injections 1 Granulocyte Colony-Stimulating Factor 1 Filgrastim 1 EC regimen 1 AMG 757 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07037758 2026-02-20

DeLLphi-311

Amgen

Phase 1 Recruiting

Extensive Stage Small Cell Lung Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡